** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.
Science Net
ICCP2D · Registering as Listener

International Conference on Cardiovascular Pharmacology and Drug Development

25–26 Aug 2026 Osaka, Japan Standard / Virtual Participation
Listener Registration From
$269
virtual · $269 in person
Registration Benefits:
Official invitation letter
Issued automatically after registration
Certificate & digital materials
Get certificate, slides and resource materials
Supporting global research
Connect with researchers across 30+ countries

1Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

2Your details

We only need what's required to register and email your confirmation. Everything else is optional.


3Coupon Code (If Any)

SPECIAL OFFER
10% OFF up to USD 30
USE COUPON CODE
FAST10
Available
Apply

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Conference Session Tracks

SDG-Aligned Research Themes

The ICCP2D conference tracks support global knowledge exchange, innovation and sustainable development priorities across Cardiology and related disciplines.

01 Advancements in Cardiovascular Pharmacology +
This track will explore recent developments in cardiovascular pharmacology, focusing on novel drug mechanisms and therapeutic targets. Participants will discuss the implications of these advancements for clinical practice and patient outcomes.
02 Innovations in Drug Development for Heart Disease +
This session will highlight cutting-edge methodologies in drug development specifically tailored for heart disease. Emphasis will be placed on the integration of technology and research in accelerating therapeutic solutions.
03 Pharmacogenomics in Cardiovascular Medicine +
This track will delve into the role of pharmacogenomics in personalizing cardiovascular treatment regimens. Discussions will focus on how genetic variations influence drug efficacy and safety in cardiac patients.
04 Clinical Trials in Cardiovascular Therapeutics +
Participants will examine the design and outcomes of recent clinical trials in cardiovascular therapeutics. The session aims to identify best practices and challenges in conducting trials that address heart disease.
05 Emerging Cardiovascular Therapies +
This session will present innovative therapeutic strategies for managing cardiovascular diseases. Attendees will explore new drug candidates and their potential impact on existing treatment paradigms.
06 Precision Medicine in Cardiology +
This track will focus on the application of precision medicine in cardiology, emphasizing tailored treatment approaches based on individual patient profiles. The discussion will include case studies and future directions in personalized cardiovascular care.
07 Drug Discovery Techniques in Cardiovascular Research +
Participants will explore novel drug discovery techniques that are shaping the future of cardiovascular research. The session will highlight interdisciplinary approaches that enhance the identification of effective cardiovascular agents.
08 Challenges in Cardiovascular Drug Development +
This track will address the multifaceted challenges encountered in the development of cardiovascular drugs. Discussions will include regulatory hurdles, market access issues, and strategies to overcome these barriers.
09 Cardiology Innovations: From Bench to Bedside +
This session will showcase innovative cardiology practices that translate laboratory findings into clinical applications. Emphasis will be placed on collaboration between researchers and clinicians to improve patient care.
10 Regulatory Frameworks in Cardiovascular Drug Approval +
This track will examine the regulatory frameworks governing the approval of cardiovascular drugs. Participants will discuss the implications of these regulations on drug development timelines and patient access.
11 Future Directions in Cardiovascular Pharmacotherapy +
This session will explore future trends and directions in cardiovascular pharmacotherapy. Attendees will engage in discussions about emerging therapies and the evolving landscape of cardiovascular treatment.

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10